Introduction
Cardiovascular disease (CVD) includes four major areas: coronary heart disease, cerebrovascular disease, peripheral artery disease and aortic atherosclerosis, and thoracic or abdominal aortic aneurysm. CVD is the number one cause of death globally. An estimated 17.9 million people died from CVD in 2016, representing 31% of all global deaths [1] . CVDs are also the leading cause of death, hospitalizations and medical costs in United States [2, 3] . An estimated 80% of CVDs are preventable [4] . Cardiac risk assessment is the cornerstone for aiding appropriate delivery of preventive therapy, and yet there are few risk models applicable to minority U.S. populations, this is particularly applicable to the South Asian sub-population.
Epidemiology
Asian Americans are the fastest-growing major racial or ethnic group in the United States. Six origin groups -Chinese, Indian, Filipino, Vietnamese, Korean and Japanese -account for 85% of all Asian Americans as of 2015 [5] . According to the U.S. Census bureau, the total population of Asian Americans grew by 43 percent from 10.2 million in 2000 to 14.7 million in 2010, which constituted the largest increase of any major racial group during that period [6] . Furthermore, South Asian Americans Living Together (SAALT) estimates up to 5.4million South Asian Americans lived in the United States in 2017 [7] . Heart disease is the leading cause of death in the Asian American population, but disparities exist in terms of the course of diagnosis and treatment. Asian Americans have higher mortality rates and die at an earlier age from stroke compared to White Americans; and CVD, especially coronary heart disease, tends to occur earlier in life and in a higher percentage of the population in Asian Indians than in other ethnic groups. This data may, in part, be linked to the lack of an evidence-based screening tool designed specifically for Asian American [8] .The 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease suggests using the race and sex specific Pooled Cohort Equation for cardiac risk assessment but does note this is best validated for non-Hispanic Whites and non-Hispanic blacks [9] . The risk models tend to either overestimate or underestimate risk in Asian populations [10] [11] [12] [13] [14] .
Even among Asian populations, risks are higher in South Asians [13, 14] . Varying estimates note Asian Indians to have up to 4 times higher risk of coronary artery disease than the average American population, and 20 times higher than Japanese population [15] [16] [17] [18] .
Risk Factors
Studies have shown that Asian Indians had similar overall body fat percentage at significantly lower overall Body Mass index (BMI) compared to Caucasian populations (BMI of 24kg/m2 for men, and 26kg/m2 for women in Asian Indians compared to BMI of 30kg/ m2 at an average for Europeans) [19] . This was also deemed due to higher abdominal fat, higher overall fat percentage, lower lean mass, and lower skeletal and bone mineral mass compared to Caucasian and European populations. The Indian Subcontinent population notes much higher prevalence of hypertriglyceridemia, high total cholesterol to high-density lipoprotein (HDL), and central obesity [20] . As such, they are noted to suffer higher cardiovascular morbidity and mortality at a much lower BMI or waist circumference [20] . Nontraditional risk factors that are not included in the conventional risk models are also more prevalent in South Asians. Immigrants from the Indian subcontinent who 
Joint European Society of Cardiology (Joint ESC) Guidelines
The Joint ESC recommends using SCORE system to establish the 10-year risk of fatal cardiovascular disease [25] . However, the accuracy of this traditional 10-year risk assessment tool is unknown in non-Caucasian populations. Admittedly, "Ethnicity should be considered in CVD risk assessment" is noted as a Class
IIa, Level A indication. Joint ESC guidelines acknowledge that South
Asians and sub-Saharan Africans are at higher risk of cardiovascular disease, while Chinese and South Americans are at a lower risk as compared to European Caucasian population. SCORE 10-year CVD risk assessment tool does not include diabetes mellitus as part of its risk calculation which may account for its limited usefulness in the South Asian population since other risk factors remain similar but poorer glycemic control has been noted [26] [27] [28] . The link of central obesity and increased waist measurement with increased CVD remains firm, with again the caveat that these measurements are based on Caucasian populations.
ETHRISK Calculator
The ETHRISK calculator uses the Framingham risk score and re-calculates the 10-year CVD risk based on the relatively increased cardiovascular risk burden ethnic minority populations [29] .
The study included 8,332 people (3778 men and 4544 women) And yet none of these markers seems to have a genomic cause based on data from Indian migrants to England. This raises question of a missing causative factor [30] .
QRISK 3 (2018) Calculator
The QRISK3 cardiovascular risk calculator is based on the QRESEARCH database that takes advantage of a large centralized database of 7.89 million people available through the UK National Health Service data from general practices between 1993-2015 [31] . While 88% of the population in the QRESEARCH database was . And yet when applied to a local native population this seemed to elevate overall risk by 50% as compared to self-reported event rates thrusting doubt upon its actual utility [32] .
Opportunity for Further Study
Traditional risk scoring systems have not been clearly validated in minority populations. Within the U.S., South Asians are a subset who have vastly different risk profiles; younger age, lower BMI than the White Caucasian populations. It is important for clinicians to be aware of the limitations of the widely used risk stratification tools. With the increasing adoption of electronic health records across the country, we have the opportunity to study large numbers of patients over time and validate or create new risk models, for minority populations. Given the worsening epidemic and outcomes in the South Asian population, it is important that public health agencies, funders, researchers, and physicians work on identifying risk factors in this population.
